| Title |
Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention
|
|---|---|
| Published in |
PharmacoEconomics - Open, October 2019
|
| DOI | 10.1007/s41669-019-00186-7 |
| Pubmed ID | |
| Authors |
Itziar Oyagüez, Carmen Suárez, José Luis López-Sendón, José Ramón González-Juanatey, Fernando de Andrés-Nogales, Jorge Suárez, Carlos Polanco, Javier Soto |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Canada | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 42 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 5 | 12% |
| Student > Ph. D. Student | 5 | 12% |
| Student > Master | 4 | 10% |
| Researcher | 4 | 10% |
| Other | 2 | 5% |
| Other | 7 | 17% |
| Unknown | 15 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 10 | 24% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 14% |
| Nursing and Health Professions | 3 | 7% |
| Business, Management and Accounting | 2 | 5% |
| Psychology | 2 | 5% |
| Other | 4 | 10% |
| Unknown | 15 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2021.
All research outputs
#6,538,833
of 23,170,347 outputs
Outputs from PharmacoEconomics - Open
#117
of 333 outputs
Outputs of similar age
#122,258
of 363,105 outputs
Outputs of similar age from PharmacoEconomics - Open
#5
of 13 outputs
Altmetric has tracked 23,170,347 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 333 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.6. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 363,105 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.